BioMedicines files for IPO

BioMedicines filed to raise up to $57.5 million in an IPO underwritten by UBS Warburg; U.S. Bancorp Piper Jaffray; and Pacific Growth Equities. BioMedicines (Alameda, Calif.) acquires and develops che...